Bristol-Myers Squibb

Follow
- + Create new list

OverviewSuggest Edit

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. The Company's medicines are helping numerous patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others.

Type	Public
Founded	1887
HQ	New York, US	Map
Website	bms.com
Employee Ratings	3.7	More

View Jobs (702)

Locations

Bristol-Myers Squibb is headquartered in
New York, United States

Location Map

All Locations (187)

Latest Updates

Employees (est.) (Nov 2018)	23,700
Job Openings	702
Revenue (FY, 2017)	$20.8 B	(+7%)
Share Price (Feb 2019)	$51	(+3%)

Key People/Management at Bristol-Myers Squibb

Giovanni Caforio

Giovanni Caforio

Chairman of the Board and Chief Executive Officer

Charles Bancroft

Charles Bancroft

Executive Vice President, Chief Financial Officer and Global Business Operations

Paul Biondi

Paul Biondi

Senior Vice President, Strategy and Business Development

Adam Dubow

Adam Dubow

Senior Vice President, Chief Compliance and Ethics Officer

John Elicker

John Elicker

Senior Vice President, Corporate Affairs and Investor Relations

Ann Powell Judge

Ann Powell Judge

Senior Vice President, Chief Human Resources Officer

Report incorrect company information

Bristol-Myers Squibb Office Locations

Bristol-Myers Squibb has offices in New York, Albany, Albuquerque, Alexandria and in 181 other locations

New York, US (HQ)

345 Park Avenue

Braine-l'Alleud, BE

4, Avenue de Finlande

Pudong Xinqu, CN

133 Fute N Rd

Rueil-Malmaison, FR

3 Rue Joseph Monier

Nagoya-shi, JP

12

Shinjuku-ku, JP

1

Report incorrect company information

Bristol-Myers Squibb Financials and Metrics

Bristol-Myers Squibb Revenue

Embed Graph

View revenue for all periods

Bristol-Myers Squibb's revenue was reported to be $20.78 b in FY, 2017

Summary

USD
Revenue (Q3, 2018)	5.7b
Gross profit (Q3, 2018)	4.0b
Gross profit margin (Q3, 2018), %	71%
Net income (Q3, 2018)	1.9b
Market capitalization (13-Feb-2019)	83.2b
Closing stock price (13-Feb-2019)	51.0
Cash (30-Sep-2018)	5.4b
EV	83.5b

Bristol-Myers Squibb's current market capitalization is $83.2 b.

Income Statement

Annual

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018
Revenue	4.1b	3.8b	3.9b	3.9b	4.0b	4.2b	4.1b	4.4b	4.9b	4.9b	4.9b	5.1b	5.3b	5.2b	5.7b	5.7b
Cost of goods sold	1.2b	968.0m	991.0m	1.0b	847.0m	1.0b	1.1b	1.1b	1.2b	1.3b	1.3b	1.6b	1.6b	1.6b	1.6b	1.6b
Gross profit	2.9b	2.8b	2.9b	2.9b	3.2b	3.2b	3.0b	3.3b	3.7b	3.6b	3.7b	3.6b	3.7b	3.6b	4.1b	4.0b
Gross profit Margin, %	71%	75%	75%	74%	79%	76%	73%	76%	75%	73%	74%	70%	70%	69%	72%	71%

Balance Sheet

Annual

Quarterly

USD	Q1, 2014	Q2, 2014	Q3, 2014	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018
Cash	5.2b	4.3b	4.9b	4.2b	4.0b	2.6b	2.9b	3.4b	3.9b	3.5b	4.6b	5.3b	5.0b	5.4b
Accounts Receivable	3.3b	3.3b	3.3b	3.7b	3.9b	5.0b	5.6b	5.6b	5.5b	5.8b	5.9b	5.7b	5.6b	5.9b
Inventories	1.7b	1.7b	1.6b	1.3b	1.1b	1.3b	1.4b	1.5b	1.4b	1.2b	1.3b	1.2b	1.2b	1.3b
Current Assets	14.0b	14.1b	14.2b	13.1b	12.9b	11.2b	12.3b	13.2b	13.6b	14.3b	15.0b	14.6b	13.9b	14.9b

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Net Income	2.6b	2.0b	1.6b	4.5b	975.0m
Inventories	(45.0m)	(254.0m)	97.0m	(152.0m)	(29.0m)
Accounts Payable	412.0m	(44.0m)	(919.0m)	104.0m	320.0m
Cash From Operating Activities	3.5b	3.1b	1.8b	2.9b	5.3b

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017	Q3, 2017	Q1, 2018	Q2, 2018	Q3, 2018
Net Income	1.8b	936.0m	1.3b	2.0b	1.2b	1.1b	1.8b	1.2b	2.4b	3.6b	1.5b	2.4b	3.3b	1.5b	1.9b	3.8b
Depreciation and Amortization																465.0m
Inventories	(8.0m)	(144.0m)	(157.0m)	(162.0m)	51.0m	162.0m	231.0m	(44.0m)	(111.0m)	(107.0m)	(71.0m)	(58.0m)	7.0m	(4.0m)	(122.0m)
Accounts Payable	301.0m	(12.0m)	(112.0m)	63.0m	(83.0m)	(618.0m)	(1.2b)	(77.0m)	(36.0m)	(142.0m)	(114.0m)	(85.0m)	63.0m	(241.0m)	(101.0m)	(186.0m)

Ratios

Show all financial metrics

Bristol-Myers Squibb Operating Metrics

Show all operating metrics

Bristol-Myers Squibb Acquisitions / Subsidiaries

Acquired Company	Date	Deal Size
Celgene	January 03, 2019	$74 b

Report incorrect company information

Competitors

Johnson & Johnson

Healthcare - Public

Healthcare - Public

Healthcare - Public

Healthcare - Public

Compare competitors

Bristol-Myers Squibb Online and Social Media Presence

128.6k Twitter followers

6 Months

Bristol-Myers Squibb has 128.6k Twitter Followers. The number of followers has increased 0.4% month over month and increased 1.6% quarter over quarter

Embed Graph

Report incorrect company information

Bristol-Myers Squibb Company Life and Culture

Report incorrect company information

Bristol-Myers Squibb Frequently Asked Questions

When was Bristol-Myers Squibb founded?
Bristol-Myers Squibb was founded in 1887.
Who are Bristol-Myers Squibb key executives?
Bristol-Myers Squibb's key executives are Giovanni Caforio, Charles Bancroft and Paul Biondi.
How many employees does Bristol-Myers Squibb have?
Bristol-Myers Squibb has 23,700 employees.
What is Bristol-Myers Squibb revenue?
Latest Bristol-Myers Squibb annual revenue is $20.8 b.
What is Bristol-Myers Squibb revenue per employee?
Latest Bristol-Myers Squibb revenue per employee is $876.6 k.
Who are Bristol-Myers Squibb competitors?
Competitors of Bristol-Myers Squibb include Johnson & Johnson, Novartis and Eli Lilly.
Where is Bristol-Myers Squibb headquarters?
Bristol-Myers Squibb headquarters is located at 345 Park Avenue, New York.
Where are Bristol-Myers Squibb offices?
Bristol-Myers Squibb has offices in New York, Albany, Albuquerque, Alexandria and in 181 other locations.
How many offices does Bristol-Myers Squibb have?
Bristol-Myers Squibb has 187 offices.